Elicio Therapeutics (ELTX) Other Operating Expenses (2020 - 2024)

Elicio Therapeutics (ELTX) has 5 years of Other Operating Expenses data on file, last reported at $3000.0 in Q1 2024.

• For the quarter ending Q1 2024, Other Operating Expenses changed N/A year-over-year to $3000.0; the trailing twelve-month figure through Dec 2024 stood at $3000.0 (changed N/A YoY), and the FY2024 full-year result was $3000.0, changed N/A from the prior year.
• Other Operating Expenses for Q1 2024 stood at $3000.0, down from $105000.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $433000.0 in Q4 2021 and bottomed at -$3.1 million in Q4 2022.
• The 5-year median for Other Operating Expenses is $115500.0 (2020), against an average of -$431700.0.
• The widest annual swing landed in 2021, when Other Operating Expenses soared 243.65%; it then slumped 826.56% in 2022.
• A 5-year view of Other Operating Expenses shows it stood at $126000.0 in 2020, then jumped by 243.65% to $433000.0 in 2021, then plunged by 826.56% to -$3.1 million in 2022, then soared by 103.34% to $105000.0 in 2023, then plunged by 97.14% to $3000.0 in 2024.
• The last three Other Operating Expenses figures came in at $3000.0 (Q1 2024), $105000.0 (Q4 2023), and -$105000.0 (Q3 2023), per Business Quant data.

Peer Comparison